Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy

Shim, KG, Zaidi, S, Thompson, J et al. (8 more authors) (2017) Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy. Molecular Therapy, 25 (4). pp. 962-975. ISSN 1525-0016

Abstract

Metadata

Authors/Creators:
  • Shim, KG
  • Zaidi, S
  • Thompson, J
  • Kottke, T
  • Evgin, L
  • Rajani, KR
  • Schuelke, M
  • Driscoll, CB
  • Huff, A
  • Pulido, JS
  • Vile, RG
Copyright, Publisher and Additional Information: (c) 2017 Under a Creative Commons license (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Keywords: oncolytic virotherapy; checkpoint inhibitors; tumor therapy
Dates:
  • Published: 5 April 2017
  • Accepted: 26 January 2017
  • Published (online): 22 February 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 16 Aug 2018 13:33
Last Modified: 16 Aug 2018 13:34
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ymthe.2017.01.023

Share / Export

Statistics